This is the authors' abstract. We don't add key points for this paper.
The detection of biomarkers in body fluids is useful for the early detection of diseases or preventive medical care. Various types of equipment that detect biomarkers have been developed and used for various occasions. It is expected that further improvement of the detection sensitivity of biomarkers will enable the extension for their applications to various diseases. In this paper, we propose a new biomarker sensing system with higher sensitivity. In the system, by combining optical disc technologies and nanobead technologies, we developed a new sensing method. Target biomarkers are specifically immobilized onto the optical disc surface through an antigen-antibody reaction, then the nanobeads are immobilized on top of the biomarkers. Since the biomarkers and beads bind to each other one-on-one, the number of target biomarkers can be measured by counting the number of nanobeads using an optical pickup. The most significant advantage of this method is that measurement can be carried out in a fully digital scheme, in contrast to current sensing systems which measure light intensity in an analog scheme.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Tsujita et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: